Literature DB >> 22242846

Recent advances in plasmepsin medicinal chemistry and implications for future antimalarial drug discovery efforts.

Marvin J Meyers1, Daniel E Goldberg.   

Abstract

Plasmepsins are the aspartic proteases of Plasmodium that play key roles in the survival of the parasite in its host. The plasmepsins of the digestive vacuole play an important role in hemoglobin degradation, providing the parasite with a vital source of nutrients. Recently, plasmepsin V has been shown to be an essential protease, processing hundreds of parasite proteins for export into the host erythrocyte. The functions of the remaining plasmepsins have yet to be discovered. Over the past decade, much effort has been placed towards developing plasmepsin inhibitors as antimalarial agents, particularly targeting the digestive vacuole. This review will highlight some of the recent work in this field with a particular focus on target druggability and strategies for identifying plasmepsins inhibitors as effective antimalarial drugs. Given recent advances in understanding the fundamental roles of the various plasmepsins, it is likely that the most effective antimalarial plasmepsin targets will be the non-digestive vacuole plasmepsins.

Mesh:

Substances:

Year:  2012        PMID: 22242846     DOI: 10.2174/156802612799362959

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  25 in total

1.  Plasmepsin V shows its carnivorous side.

Authors:  Daniel E Goldberg
Journal:  Nat Struct Mol Biol       Date:  2015-09       Impact factor: 15.369

2.  In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.

Authors:  Anthony Bouillon; David Giganti; Christophe Benedet; Olivier Gorgette; Stéphane Pêtres; Elodie Crublet; Christine Girard-Blanc; Benoit Witkowski; Didier Ménard; Michael Nilges; Odile Mercereau-Puijalon; Véronique Stoven; Jean-Christophe Barale
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

Review 3.  Malaria parasite plasmepsins: More than just plain old degradative pepsins.

Authors:  Armiyaw S Nasamu; Alexander J Polino; Eva S Istvan; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2020-05-04       Impact factor: 5.157

4.  Evaluation of aminohydantoins as a novel class of antimalarial agents.

Authors:  Marvin J Meyers; Micky D Tortorella; Jing Xu; Limei Qin; Zhengxiang He; Xingfen Lang; Wentian Zeng; Wanwan Xu; Li Qin; Michael J Prinsen; Francis M Sverdrup; Christopher S Eickhoff; David W Griggs; Jonathan Oliva; Peter G Ruminski; E Jon Jacobsen; Mary A Campbell; David C Wood; Daniel E Goldberg; Xiaorong Liu; Yongzhi Lu; Xin Lu; Zhengchao Tu; Xiaoyun Lu; Ke Ding; Xiaoping Chen
Journal:  ACS Med Chem Lett       Date:  2013-12-06       Impact factor: 4.345

5.  Deciphering the mechanism of potent peptidomimetic inhibitors targeting plasmepsins - biochemical and structural insights.

Authors:  Vandana Mishra; Ishan Rathore; Anagha Arekar; Lakshmi Kavitha Sthanam; Huogen Xiao; Yoshiaki Kiso; Shamik Sen; Swati Patankar; Alla Gustchina; Koushi Hidaka; Alexander Wlodawer; Rickey Y Yada; Prasenjit Bhaumik
Journal:  FEBS J       Date:  2018-07-07       Impact factor: 5.542

6.  Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases.

Authors:  Budhaditya Mukherjee; Francesca Tessaro; Juha Vahokoski; Inari Kursula; Jean-Baptiste Marq; Leonardo Scapozza; Dominique Soldati-Favre
Journal:  EMBO J       Date:  2018-03-08       Impact factor: 11.598

7.  4-Aryl Pyrrolidines as a Novel Class of Orally Efficacious Antimalarial Agents. Part 1: Evaluation of 4-Aryl- N-benzylpyrrolidine-3-carboxamides.

Authors:  Marvin J Meyers; Jianguang Liu; Jing Xu; Fang Leng; Jiantong Guan; Zhijun Liu; Sarah A McNitt; Limei Qin; Linglin Dai; Hongwei Ma; Dickson Adah; Siting Zhao; Xiaofen Li; Alex J Polino; Armiyaw S Nasamu; Daniel E Goldberg; Xiaorong Liu; Yongzhi Lu; Zhengchao Tu; Xiaoping Chen; Micky D Tortorella
Journal:  J Med Chem       Date:  2019-03-22       Impact factor: 7.446

8.  Structures of plasmepsin II from Plasmodium falciparum in complex with two hydroxyethylamine-based inhibitors.

Authors:  Rosario Recacha; Janis Leitans; Inara Akopjana; Lilija Aprupe; Peteris Trapencieris; Kristaps Jaudzems; Aigars Jirgensons; Kaspars Tars
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-11-27       Impact factor: 1.056

9.  The zymogen of plasmepsin V from Plasmodium falciparum is enzymatically active.

Authors:  Huogen Xiao; Brian C Bryksa; Prasenjit Bhaumik; Alla Gustchina; Yoshiaki Kiso; Shao Q Yao; Alexander Wlodawer; Rickey Y Yada
Journal:  Mol Biochem Parasitol       Date:  2014-10-25       Impact factor: 1.759

10.  Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes.

Authors:  Anthony N Hodder; Brad E Sleebs; Peter E Czabotar; Michelle Gazdik; Yibin Xu; Matthew T O'Neill; Sash Lopaticki; Thomas Nebl; Tony Triglia; Brian J Smith; Kym Lowes; Justin A Boddey; Alan F Cowman
Journal:  Nat Struct Mol Biol       Date:  2015-07-27       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.